about
Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolismAssociation between computed tomography obstruction index and mortality in elderly patients with acute pulmonary embolism: A prospective validation study.The adherence to initial processes of care in elderly patients with acute venous thromboembolismAdjudication-related processes are underreported and lack standardization in clinical trials of venous thromboembolism: a systematic review.Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism.Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.Computer usage and task-switching during resident's working day: Disruptive or not?Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study.Who Orders a Head CT?: Perceptions of the Cirrhotic Bleeding Risk in an International, Multispecialty Survey Study.Allocation of Internal Medicine Resident Time in a Swiss Hospital: A Time and Motion Study of Day and Evening Shifts.Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.Quality of life after pulmonary embolism: Prospective validation of the German version of the PEmb-QoL questionnaire.Do Hospital Doctors Screen for Diabetes?In-hospital mortality is associated with high NT-proBNP levelA 10-year observational study on the trends and determinants of smoking statusDo hospital doctors test for thrombophilia in patients with venous thromboembolism?Derivation and Validation of a Prediction Model for Risk Stratification of Post-Thrombotic Syndrome in Elderly Patients with a First Deep Vein ThrombosisAssociation Between Physical Activity Levels in the Hospital Setting and Hospital-Acquired Functional Decline in Elderly PatientsElevated HbA1c is not associated with recurrent venous thromboembolism in the elderly, but with all-cause mortality- the SWEETCO 65+ studyInter-hospital comparison of working time allocation among internal medicine residents using time-motion observations: an innovative benchmarking toolComparison of Swiss and European risk algorithms for cardiovascular prevention in SwitzerlandAssociation between insurance status, anticoagulation quality, and clinical outcomes in patients with acute venous thromboembolismGut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolismDevelopment and multi-cohort validation of a clinical score for predicting type 2 diabetes mellitusA high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort studyStatin therapy and recurrent venous thromboembolism in the elderly: a prospective cohort studyClinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolismHigh-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolismValidation of Seven Type 2 Diabetes Mellitus Risk Scores in a Population-Based Cohort: The CoLaus StudyAnticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolismRisk stratification of elderly patients with acute pulmonary embolism
P50
Q33417203-4A266A0A-C8FD-4FFB-A04F-F5FB2BB10B73Q33778707-73921AED-2B01-4116-A386-4D940FCA011AQ33830642-DFC109E0-8494-4E9E-BE61-D52F3608D00AQ35056799-1F670C06-8932-4A36-997D-03376A74E75AQ36028048-060F89DB-6FBE-4972-9D92-702F74833ABDQ36126175-1B912557-D24A-4D97-BE2B-EEDAB741320FQ36290254-B5441798-5F65-475F-B5F0-5611CD41484CQ40506524-95D8F524-ADF2-48E0-85EC-56B97E04B793Q41702785-EEB1F70F-DC31-4869-95C4-BF1463319408Q47376941-196833B1-651F-4FE4-853C-1DD2235D4DF3Q47449777-2D0B10A2-5EEA-41A7-BB9E-FB3BBF18F13DQ47564368-9A693AEE-E0BB-4684-B2A2-A47C0BD7C7F7Q47728750-7D83C42C-ADD9-4DBE-AF22-DFF9EEF5590FQ48040675-C2A484F7-675B-4318-8E06-D3000EEF6CE8Q57180775-C86E3539-F77C-4A43-900D-91CA9BD5CCB8Q58588208-1FF40DC1-938F-4687-96FE-C03A3A2B0291Q59660473-472A8655-9100-4D97-8DCB-FEC51DCAC667Q64936127-9ADA7542-FD77-4E43-971F-BB6E9E13123EQ89362773-425B2536-3070-46B2-946E-57B44560B9ADQ89465035-AA3F3C95-869E-4771-B03E-BFA0BF94BB51Q89686433-B4E3926A-BE9F-4D05-B61E-EB4D2A392C9EQ89747044-C13AFFC7-33D3-48EC-BD1C-F8321AD8C73BQ89846784-C9F91E39-BF4E-4094-90A2-0BCB490767C3Q90357785-5C9619C5-2F64-49EF-8968-5CD8F7E0B5EBQ90544244-7CA7DA40-5CE6-4669-A11E-FD85B912AAFFQ90610687-3161F320-16C9-4855-B1AB-6528E1DB3E7BQ90665089-DD2E640F-8010-4CBD-A7FF-0BD3203C6A12Q90730887-37AC8B02-7303-411C-84C4-186F6D6DA724Q91091651-76E9F651-0B1D-460F-B8B4-9E4058C37080Q91297479-62A2E30B-7D7D-4CA9-93ED-E215715409D1Q91536081-96597037-E131-42BA-93F7-8E1B093C6C45Q92076783-64209922-ADFC-43DC-84B1-B0A849102B6AQ93071525-A891D814-AEDD-4FAC-A5E7-4FF5AD3F3885
P50
description
researcher
@en
wetenschapper
@nl
name
M Méan
@en
M Méan
@nl
type
label
M Méan
@en
M Méan
@nl
prefLabel
M Méan
@en
M Méan
@nl
P31
P496
0000-0003-0477-7899